Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Neuro-Oncology Advances|February 10, 2026
Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgeryTroy J Kleber, Denái R Milton, Subhiksha Srinivasan, et al.
Nature Cancer|March 19, 2026
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study resultsRashmi K Murthy, Barbara J O'Brien, Donald A Berry, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Incorporating an NCCN-Based Systemic Therapy CNS Activity Score Into SRS Decision-Making for Patients With 5 or More Brain MetastasesThomas H Beckham, Stephanie O Dudzinski, Michael K Rooney, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Acta Neuropathologica Communications|April 14, 2025
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasisSwaminathan Kumar, Meredith S Pelster, Merve Hasanov, et al.
Neuro-Oncology|November 23, 2019
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophagesJohn de Groot, Marta Penas-Prado, Kristin Alfaro-Munoz, et al.
Neuro-Oncology|December 13, 2022
Changes in outcomes and factors associated with survival in melanoma patients with brain metastasesMerve Hasanov, Denái R Milton, Alicia Bea Davies, et al.
Nature Communications|March 10, 2026
Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastomaJongHoon Ha, Yifan Wang, Yifan Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III MelanomaLauren E Haydu, Serigne N Lo, Jennifer L McQuade, et al.
Pageof 9